AACR and CEO Dr. Margaret Foti receive award for raising public awareness about melanoma

November 14, 2003

The American Association for Cancer Research and its CEO, Margaret Foti, Ph.D., M.D. (h.c.), received the CommunityCaring Award from the William S. Graham Foundation for Melanoma Research, Inc., (The "Billy Foundation") for "going above and beyond" what other organizations have done to help educate the public and survivors about cancer. Through its educational programs, the AACR has raised public awareness about the importance of prevention and early detection of melanoma. About 54,200 new cases of malignant melanoma will be diagnosed in the U.S. this year; about 7,600 people will die of this disease.

The award was presented to Dr. Foti on Saturday, November 8, 2003, at the Foundation's 5th Annual "SunSafe Moonlit Night Gala," held at the Pan Pacific Hotel in San Francisco, Calif.

"We are very pleased that Dr. Foti is the 2003 recipient of this award for the role she and the AACR played in promoting the public awareness programs of the 'Billy Foundation' through their Annual Meetings and Public Forums, and their assistance in the early detection of melanoma via their hosting of the Foundation's Mole Patrol/free skin cancer screenings," said Karen L. Graham, chair and president of the William S. Graham Foundation for Melanoma Research, Inc.

"Together with all of this, the AACR's Scientist?Survivor Program has hosted the 'Billy Foundation' for the past several years, thus allowing the ongoing training of the Foundation, and enabling us to bring back to our constituents the cutting edge information on cancer research."

Added Dr. Foti: "The AACR is deeply committed to the goals and objectives of the 'Billy Foundation,' and together we will succeed in our fight against this disease. This special honor must be shared with the extraordinary colleagues with whom I have had the pleasure to work through the years."

The AACR has taken a leadership role in building effective alliances with survivor and patient advocacy groups, like the "Billy Foundation," through its educational programs and Annual Meeting, the largest meeting in the world devoted to cancer research. For example:Recently, the AACR and the "Billy Foundation" also joined to create a new award, the AACR-William S. Graham Foundation Fellows Grant for Melanoma Research, to provide direct research support to an outstanding clinical or postdoctoral fellow in the U.S. This fellowship will be awarded for the first time March 27-31, 2004, at the AACR's Annual Meeting in Orlando, Fla.

"Because of the spectacular science being done today, as well as important life-saving, lifestyle modifications, cancer rates are dropping," said Dr. Foti. "However, the number of new cancer cases is still going up. Melanoma cases in the U.S. are increasing, and the disease is being detected in younger individuals.

"So many more will succumb to cancer and its devastating effects unless we redouble our efforts and our energies and make cancer research and cancer prevention a national priority."

Other award winners include:Charles M. Balch, M.D., professor of surgery and oncology at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University in Baltimore, Md., and executive vice president and CEO of the American Society of Clinical Oncology (ASCO), delivered a keynote address on melanoma research and its direction in the future. Samantha Mohr, a meteorologist for KPIX/CBS in San Francisco, Calif., was the evening's mistress of ceremonies.
Founded in 1907, the American Association for Cancer Research (AACR) is a professional society of nearly 22,000 laboratory and clinical scientists engaged in cancer research in the United States and over 60 other countries. The AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication, and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals (Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention). The AACR's Annual Meeting attracts more than 16,000 participants who share new and significant discoveries in the cancer field, and the AACR's specialty meetings throughout the year focus on all the important areas of basic, translational, and clinical cancer research.

The William S. Graham Foundation for Melanoma Research, Inc., is a 501(c)3 non-profit organization whose primary purpose is to raise funds in support of research designated to finding the cure for the later stages of the deadly disease, malignant melanoma; to educate the public regarding the cause and prevention; and through specific public awareness programs, to assist in the early detection of this insidious, potentially lethal cancer. Karen Graham, founder and president of the "Billy Foundation," named the organization in honor of her son, Billy Graham, who succumbed to malignant melanoma in 1994 at age 22.

American Association for Cancer Research

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.